Professor Teoh, Yuen-Chun Jeremy
Associate Professor,
Department of Surgery,
Faculty of Medicine,
The Chinese University of Hong Kong
Bladder cancer is one of the most prevalent cancers worldwide, with non-muscle-invasive bladder cancer (NMIBC) accounting for 75% of bladder cancer cases.1-3 While the standard piecemeal transurethral resection of bladder tumor (SR) has be
August 6, 2024
